The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
The SIGMA Spectrum Infusion Pump with Master Drug Library (Version 8) and Spectrum IQ Infusion System with Dose IQ Safety Software (Version 9) are software-controlled infusion pumps that deliver controlled amounts of fluids such as pharmaceutical drugs, blood, and blood products and other required patient therapies. The fluids are provided through an infusion tubing set into a patient’s vein or through other cleared routes of administration. The devices are used in hospitals and other healthcare facilities.
Baxter Healthcare is recalling SIGMA Spectrum Infusion Pumps with Master Drug Library (Version 8) and Spectrum IQ Infusion Systems with Dose IQ Safety Software (Version 9) due to the risk of not alarming for repeated upstream occlusion events. After an upstream occlusion alarm, failure to fully resolve any upstream occlusion before restarting the infusion can cause the pump to not re-alarm as expected. The pump adjusts occlusion detection after the user acknowledges an upstream occlusion alarm; for the remainder of that infusion, the upstream occlusion alarm will not alarm per its baseline settings. If an occlusion is not fully resolved before restarting the infusion, the pump may not re-alarm as expected and may appear to be infusing normally, though may be infusing below the programmed rate or not infusing at all. Patient harm may occur from interruption in therapy (due to full occlusion) and/or underinfusion (due to partial occlusion).
Use of the affected products may cause serious adverse events, including death.
Baxter has received 51 reports of serious injuries and three reports of patient deaths over five years, potentially associated with this issue.
On December 29, 2021, Baxter sent an Urgent Safety Communication to all affected customers with the following instructions:
Customers with questions about this recall should contact their Baxter sales representative, or Baxter Technical Assistance at 800-356-3454 (choose option 1) Monday – Friday, between 7:00 am – 7:00pm Eastern Time.
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.
Sign up to receive email updates on medical device recalls, safety communications, and other safety information.